Reference
Leckey R, et al. Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen. Multiple Sclerosis and Related Disorders 66 : 1-5, Oct 2022. Available from: URL: http://doi.org/10.1016/j.msard.2022.104030
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1963, 26 (2023). https://doi.org/10.1007/s40278-023-42082-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-42082-8